1. Home
  2. PDSB vs ORGN Comparison

PDSB vs ORGN Comparison

Compare PDSB & ORGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDSB
  • ORGN
  • Stock Information
  • Founded
  • PDSB 2005
  • ORGN 2008
  • Country
  • PDSB United States
  • ORGN United States
  • Employees
  • PDSB N/A
  • ORGN N/A
  • Industry
  • PDSB Biotechnology: Pharmaceutical Preparations
  • ORGN Major Chemicals
  • Sector
  • PDSB Health Care
  • ORGN Industrials
  • Exchange
  • PDSB Nasdaq
  • ORGN Nasdaq
  • Market Cap
  • PDSB 72.2M
  • ORGN 72.7M
  • IPO Year
  • PDSB N/A
  • ORGN N/A
  • Fundamental
  • Price
  • PDSB $1.62
  • ORGN $0.43
  • Analyst Decision
  • PDSB Strong Buy
  • ORGN Strong Buy
  • Analyst Count
  • PDSB 2
  • ORGN 1
  • Target Price
  • PDSB $10.00
  • ORGN $3.00
  • AVG Volume (30 Days)
  • PDSB 855.2K
  • ORGN 818.7K
  • Earning Date
  • PDSB 08-12-2025
  • ORGN 08-13-2025
  • Dividend Yield
  • PDSB N/A
  • ORGN N/A
  • EPS Growth
  • PDSB N/A
  • ORGN N/A
  • EPS
  • PDSB N/A
  • ORGN N/A
  • Revenue
  • PDSB N/A
  • ORGN $29,887,000.00
  • Revenue This Year
  • PDSB N/A
  • ORGN $49.18
  • Revenue Next Year
  • PDSB N/A
  • ORGN $144.81
  • P/E Ratio
  • PDSB N/A
  • ORGN N/A
  • Revenue Growth
  • PDSB N/A
  • ORGN N/A
  • 52 Week Low
  • PDSB $0.85
  • ORGN $0.40
  • 52 Week High
  • PDSB $4.42
  • ORGN $1.90
  • Technical
  • Relative Strength Index (RSI)
  • PDSB 54.15
  • ORGN 38.07
  • Support Level
  • PDSB $1.53
  • ORGN $0.42
  • Resistance Level
  • PDSB $1.85
  • ORGN $0.47
  • Average True Range (ATR)
  • PDSB 0.14
  • ORGN 0.03
  • MACD
  • PDSB -0.01
  • ORGN 0.01
  • Stochastic Oscillator
  • PDSB 44.86
  • ORGN 24.20

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

About ORGN Origin Materials Inc.

Origin Materials Inc is a carbon-negative materials company. The platform turns the carbon found in biomass into useful materials, while eliminating the need for fossil resources and capturing carbon in the process. Its products include, PET circular caps and closures, Para-xylene, carbon black, Levulinic acid among others by using materials like food and beverage packaging, clothing, textiles, plastics, car parts, carpeting, tires, adhesives, soil amendments, and fuels.

Share on Social Networks: